2010
DOI: 10.1016/j.bbalip.2010.08.013
|View full text |Cite
|
Sign up to set email alerts
|

Altered lipoprotein metabolism in P2Y13 knockout mice

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

0
22
2

Year Published

2012
2012
2017
2017

Publication Types

Select...
7
1

Relationship

0
8

Authors

Journals

citations
Cited by 33 publications
(24 citation statements)
references
References 30 publications
0
22
2
Order By: Relevance
“…The in vivo data have to be placed in light of a non-tissue-specific removal of the receptor, and the observed neuroprotection may be due to changes in lipid metabolism, altered insulin and glucose levels affecting whole body metabolism, or embryonic changes altering the prerequisites for PA-mediated neuronal loss. This is illustrated by the finding that though phenotypic analysis of P2Y 13 −/− mice did not show changed insulin sensitivity or glucose tolerance, inhibition of P2Y 13 receptor activity in mice using MRS2211 leads to increased insulin secretion and reduced plasma glucose [15,20]. However, the here presented in vitro findings excitingly Activation of the P2Y 13 receptor in mice leads to an augmented hepatic HDL uptake and bile acid secretion [21].…”
Section: Lipid-induced Neuronal Losscontrasting
confidence: 44%
See 2 more Smart Citations
“…The in vivo data have to be placed in light of a non-tissue-specific removal of the receptor, and the observed neuroprotection may be due to changes in lipid metabolism, altered insulin and glucose levels affecting whole body metabolism, or embryonic changes altering the prerequisites for PA-mediated neuronal loss. This is illustrated by the finding that though phenotypic analysis of P2Y 13 −/− mice did not show changed insulin sensitivity or glucose tolerance, inhibition of P2Y 13 receptor activity in mice using MRS2211 leads to increased insulin secretion and reduced plasma glucose [15,20]. However, the here presented in vitro findings excitingly Activation of the P2Y 13 receptor in mice leads to an augmented hepatic HDL uptake and bile acid secretion [21].…”
Section: Lipid-induced Neuronal Losscontrasting
confidence: 44%
“…Silencing the P2Y 13 receptor results in reduced TG-HDL endocytosis and internalization [13]. Gene profiling and phenotypic analysis of P2Y 13 −/− mice confirm that they hold altered lipoprotein, cholesterol and HDL metabolism [20]. HFD has previously been shown to increase lipid droplet accumulation in intestinal muscularis propria in C57BL/6 mice [22].…”
Section: Lipid-induced Neuronal Lossmentioning
confidence: 88%
See 1 more Smart Citation
“…All of the three P2Y receptors that are preferentially activated by ADP (P2Y 1 , P2Y 12 and P2Y 13 ) have been found to be coupled to ecto-F 1 -ATPase activity and display different functions depending on the cell type [32]. For instance, in hepatocytes the apoA-I/ecto-F 1 -ATPase/P2Y 13 axis activates an intracellular RhoA/ROCKI signaling pathway that stimulates HDL uptake and appears to have atheroprotective properties by promoting reverse cholesterol transport [21-24, 30, 44, 45], and in adipocytes HDL-apoA-I, ecto-F 1 -ATPase and P2Y signaling are all involved in lipid metabolism [46-50]. In endothelial cells, apoA-I/ecto-F 1 -ATPase has been previously shown to stimulate HDL transcytosis via activation of P2Y 12 ADP receptors [20].…”
Section: Discussionmentioning
confidence: 99%
“…The extracellular ADP generated then selectively activates the P2Y13 purinergic receptor, resulting in cytoskeleton reorganization and subsequent clathrin-dependent endocytosis of whole HDL particles. P2Y13 -knockout mice displayed impaired biliary cholesterol secretions [ 64, 67- 68 ] and were prone to atherosclerosis on apoE-KO background [ 65 ] , consistent with the role of P2Y13 in HDL endocytosis by hepatocytes. Conversely, overexpression of P2Y13 in mice is atheroprotective [ 66 ] .…”
Section: Hdl-bile Acid Channelmentioning
confidence: 67%